Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Medpace Holdings, Inc.
Medpace Holdings, Inc. insider Susan E. Burwig reported changes in beneficial ownership of securities as of October 21, 2026. This filing is a standard Form 4 disclosure regarding insider stock holdings.…more
Medpace Holdings, Inc.
Medpace Holdings, Inc. has filed its Form 10-Q quarterly report for the period ended September 30, 2026. The filing includes standard certifications from management regarding the financial statements and the effectiveness of internal controls.…more
Medpace Holdings, Inc.
Medpace Holdings reported third-quarter 2026 revenue of $716.0 million and net income of $137.5 million, showing growth compared to the same period last year. Additionally, the company terminated its existing share repurchase program and approved a new authorization to repurchase up to $1.0 billion of common stock through December 31, 2028.…more
40 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Medpace Holdings Terminates Existing Buyback Authorization, Approves New $1B Share Repurchase Program Through 2028…more
Medpace Holdings has terminated its previous share repurchase authorization and approved a new $1 billion buyback program effective through 2028. This move reflects the company's ongoing commitment to capital allocation and enhancing shareholder value.…more
●●●●●●●● ●●●●● ●●●●●●
Medpace reported third-quarter earnings of $4.84 per share, surpassing analyst expectations and marking a 25.39% increase year-over-year. Quarterly revenue reached $716 million, slightly exceeding consensus estimates and showing steady growth compared to last year.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.